ecompressive craniectomy is a life-saving procedure used in the treatment of medically refractory intracranial hypertension in patients suffering from traumatic brain injury, cerebral infarction, subarachnoid hemorrhage (SAH), and intracerebral hemorrhage (ICH). 1, 8, 9, 14 Indications for cranioplasty are usually protective and cosmetic. Cranioplasty has also been reported to facilitate neurological recovery 3,15 and improve cerebral blood flow, CSF hydrodynamics, and metabolic activity after a decompressive craniectomy.
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ecompressive craniectomy is a life-saving procedure used in the treatment of medically refractory intracranial hypertension in patients suffering from traumatic brain injury, cerebral infarction, subarachnoid hemorrhage (SAH), and intracerebral hemorrhage (ICH). 1, 8, 9, 14 Indications for cranioplasty are usually protective and cosmetic. Cranioplasty has also been reported to facilitate neurological recovery 3, 15 and improve cerebral blood flow, CSF hydrodynamics, and metabolic activity after a decompressive craniectomy. [2] [3] [4] [5] [6] [7] Some patients with severe brain swelling treated with decompressive craniectomy may develop communicating hydrocephalus, with or without persistent brain bulging. Consequently, these patients also require a ventriculoperitoneal (VP) shunt to relieve the hydrocephalus.
There is no consensus as to the timing of the cranioplasty and VP shunt placement in patients who require both operations. A large cranial defect could lead to turbulence in CSF circulation hydrodynamics and cerebral blood perfusion due to exposure to atmospheric pressure, followed by hydrocephalus. [4] [5] [6] [7] Cranioplasty and VP shunts each affect CSF circulation, but exactly how each operation affects it is as yet unknown. Thus, undergoing both operations at the same time may cause complications due to unexpected CSF circulation changes. In this study, we assessed the results of undergoing cranioplasty and VP shunting at the same time in patients with cranial defects and hydrocephalus. We hypothesized that the outcomes after simultaneous cranioplasty and VP shunting may be worse than those when the operations are performed at different times.
Methods
This study was approved by the institutional review board of the Soonchunhyang University Seoul Hospital, and data were obtained by retrospective review of medical records, including radiographic images. A retrospective review was conducted in 54 patients who had undergone cranioplasty and VP shunt operations after a decompressive craniectomy for refractory intracranial hypertension between 2003 and 2012 at our institution. The interval between the cranioplasty and VP shunt placement was within 6 months. Of the 54 patients, the charts of 2 were incomplete for the purposes of this study, and 1 patient was lost to follow-up in the early postoperative period. As a result, 51 patients were identified who had undergone cranioplasty and VP shunt procedures. Baseline patient characteristics, operative details, and complication rates are shown in Table 1 . In all cranioplasty procedures, we used autologous bone, and all autologous bone had been stored in our bone bank.
We routinely checked follow-up brain CT scans in patients with brain bulging after the decompressive craniectomy; if ventricular enlargement was observed on brain CT scans, we suspected hydrocephalus. If the diagnosis of hydrocephalus was uncertain, we performed a lumbar puncture to withdraw 30 ml CSF and we obtained brain metrizamide-enhanced CT scans. We defined hydrocephalus as: 1) a bifrontal index (the ratio of maximum width of the frontal horn to the width of the inner table) greater than 0.3 on brain CT scanning or MRI; 2) progressive increase in ventricular size; 3) enlargement of the temporal horn and third ventricle; 4) periventricular decreased density on CT; 5) contrast reflux into the ventricular system with delayed clearance on brain metrizamide CT (2-and 24-hour delayed scanning after intrathecal iodine contrast injection through lumbar puncture); and 6) neurological improvement after withdrawal of CSF via lumbar puncture. The severity of hydrocephalus was categorized according to the bifrontal index, with an index greater than 0.4 regarded as severe hydrocephalus (Fig. 1) .
We inserted a programmable valve in 50 patients and a gravity-assisted valve in 1 patient; 41 patients received a Codman Hakim programmable valve (Codman & Shurtleff, Inc.), 9 received a MIETHKE proGAV (Christoph Miethke GmbH & Co. KG & BBraun), and 1 received a MIETHKE GAV shunt (Christoph Miethke GmbH & Co. KG & BBraun). We set the shunt pressure in consideration of ventricular puncture pressure and lumbar puncture pressure. The shunt pressure for most patients was set at 9-13 cm H 2 O (mean 11.38 cm H 2 O); in 26 patients the pressure was set at 11 cm H 2 O. All patients underwent brain CT scanning 7 days after surgery, and the shunt pressure was raised or lowered by 2-3 cm H 2 O. If there was neurological compromise after the operation, we checked brain CT scans immediately. If there were signs of CNS infection (such as fever, headache, and nuchal rigidity), we checked brain CT scans with contrast enhancement and CSF studies. If CNS infection was revealed by the CSF study, prophylactic antibiotics were started immediately and then were changed depending on culture.
Brain bulging was classified into 3 types: flaccid concave cranial defect, flaccid with partial convex cranial defect, and tense convex cranial defect (Fig. 2) . A flaccid concave cranial defect was designated when all the brain was under the skull line. If part of the brain was bulging above the skull line, it was defined as flaccid with a partial convex cranial defect. A tense convex cranial defect was designated when all the brain was above the skull line. We considered the former two cranial defects (flaccid concave and flaccid with partial convex) to be mild brain bulging, and a tense convex cranial defect to be severe brain bulging.
The cranial defect size was categorized according to maximum diameter: if the cranial defect size was smaller than half of the hemisphere diameter, it was regarded as a small cranial defect. A cranial defect larger than half of the hemisphere diameter was regarded as a large cranial defect.
Patients were classified according to complications. Additionally, the group with complications was classified according to whether reoperation was required. Complications requiring reoperations included infections (subdural abscess or shunt infection), subdural fluid collection, and hemorrhage that caused neurological compromise or was refractory to medical treatment. Patients with small amounts of subdural fluid collection that could be managed by adjusting the VP shunt pressure were excluded from complications requiring reoperation.
Data analyses were performed using SPSS software (version 19, SPSS, Inc.). Categorical variables were analyzed in contingency tables using Fisher's exact test; p values < 0.05 were considered to indicate statistical significance.
Results
Baseline patient characteristics and complications are shown in Table 1 . The most common indication for craniectomy was trauma (45%). Other reasons for decompressive craniectomy included SAH, ICH, and cerebral infarct. In total, 32 patients (64%) underwent cranioplasty and VP shunt placement at the same time, and the others underwent the operations at different times. In the latter group, the interval between the two operations ranged from 0.5 to 6 months (average interval, 2.4 months). The average interval between decompressive craniectomy and subsequent operation (cranioplasty or shunt placement) was 2.88 ± 1.85 months, and there was some difference between the groups. Most (86%) of the skull defects were larger than half of the hemisphere. Of the patients, 43 (84%) had tense convex cranial defects; the others had flaccid or flaccid with partial convex cranial defects. The bifrontal indices in approximately half the patients (26 patients, 51%) were less than 0.4, and those of the remaining patients were above 0.4.
Postoperative complications are summarized in Table 2. Of the 51 patients who underwent cranioplasty and VP shunt placement, 29 (57%) experienced no complication, and 22 (43%) experienced at least 1 complication. These complications included subdural fluid collection, infection, subdural hemorrhage, ICH, and epidural hemorrhage, which were diagnosed clinically and were confirmed with CT scans (Fig. 3) . Among the patients with complications, 12 (24%) had complications that required an additional surgery to address the primary cranioplasty or VP shunt site. Complications requiring reoperation were infection (subdural abscess or shunt infection), sub- dural fluid collection, or hemorrhage with neurological compromise. We encountered infections in 7 cases (Table 3) . Pathogens were methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, and Enterobacter spp. Primary sites of infection were epidural abscess, CSF, and distal or peritoneal catheter. A cure was obtained with surgery and antibiotics in 5 patients, but 2 patients died. Data regarding categorical variables and complications are summarized in Table 4 . Statistical analysis showed that the degree of brain bulging was significantly associ- (Table 5 ), the timing of the two operations was not statistically significantly associated with complications; however, the patients undergoing simultaneous cranioplasty and VP shunt placement showed a tendency toward a higher complication rate and more severe complications. Cranial defect size, severity of hydrocephalus, indication for decompressive cranioplasty, age, sex, and interval between decompressive craniectomy and subsequent operation did not affect complication rates.
Discussion
Decompressive craniectomy is a significant part of neurosurgical practice, as is the requirement for subsequent cranioplasty. However, while cranioplasty may be integral, no comprehensive guidelines are available regarding the technique or timing of the procedure, especially with regard to possible complications. Current practices relating to cranioplasty are largely subjective and are based on surgeon preferences or institutional policies. 16 Hydrocephalus is a common complication of decompressive craniectomy. 18, 19 When hydrocephalus develops in a patient after a decompressive craniectomy, the brain may progressively bulge at the craniectomy site. In this situation, there is little doubt about the need for shunting.
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The overall complication rate of cranioplasty is 16%-34%, depending on the study.
7,12,16 Wu et al. reported that the cumulative complication rate of VP shunting at 5 years was 32%. 17 In our study, the overall complication rate was 43%. Patients undergoing both operations at the same time and patients with large cranial defect and severe brain bulging had much higher complication rates (56%, 45%, and 51%, respectively) than previously published complication rates for cranioplasty and shunt placement. However, patients undergoing the two operations at different times had a lower complication rate (21%). Rocque et al. reported that there is no considerable effect of craniectomy defect size on complication rate. Also, time between craniectomy and cranioplasty did not have a significant effect on complication rate. 13 The results came from studies in the pediatric population but were consistent with our study. In contrast to our study, Zhou et al. reported that the outcome of a single-stage operation combining VP shunt placement and cranioplasty did not significantly differ from that for two separate operations. 20 More research on the safety of a single-stage operation is needed.
The brain with a skull bone defect is affected by several factors that do not affect the brain without such a defect. The general purpose of cranioplasty is cosmetic and protection from external impact, but some authors have also suggested that cranioplasty can result in neurological improvement, 3, 15 which has been explained by several theories. According to the literature, cranioplasty protects the brain from the effects of barometric pressure, so it affects the cerebral vasculature and cerebral perfusion pressure; this can change the intracranial pressure. [3] [4] [5] 10 We also presume that performing cranioplasty in the presence of a sunken or bulging brain creates a negative or positive pressure, respectively, in the subdural space. Secondarily, this may also change the intracranial pressure. Because of these changes in intracranial pressure, adjusting the VP shunt pressure is difficult. Indeed, how best to adjust VP shunt pressure has not been defined in patients undergoing cranioplasty and VP shunt placement. Most of the patients undergoing simultaneous cranioplasty and VP shunt placement who had complications had subdural fluid collection or subdural hematoma. Such complications could be caused, or aggravated, by CSF drainage via the VP shunt. 17 The higher complication rate in patients undergoing the two operations at the same time may be explained by difficulties in adjusting the VP shunt pressure in these patients.
Our study was retrospective in nature and, as such, does not provide rigorous evidence supporting any particular course of action, especially the small cohorts, the selection bias in determining which patients would have both procedures simultaneously, and certain nonquantitative outcome measures. However, it does illustrate some important observations that we think are useful to consider. Simultaneous cranioplasty and VP shunt placement was associated with a tendency toward higher complica- 
Conclusions
Cranioplasty and shunt placement, two procedures performed after decompressive craniectomy, have higher complication rates than do other elective cranial procedures. In our study, patients who underwent cranioplasty and VP shunt placement at the same time tended to have higher complication rates. Patients with severe brain bulging also had a higher complication rate. We conclude that simultaneous cranioplasty and VP shunt placement should be avoided, especially in patients with severe brain bulging. Furthermore, because complications caused or aggravated by CSF drainage via the VP shunt were frequent in our study, cautious adjustment of VP shunt pressure is required. However, our data are too limited to draw definite conclusions. Prospective studies are needed to further evaluate cranioplasty with VP shunting.
